(19)
(11) EP 2 043 637 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
28.03.2012 Bulletin 2012/13

(45) Mention of the grant of the patent:
04.01.2012 Bulletin 2012/01

(21) Application number: 07813027.5

(22) Date of filing: 17.07.2007
(51) International Patent Classification (IPC): 
A61K 31/426(2006.01)
A61K 31/192(2006.01)
(86) International application number:
PCT/US2007/073716
(87) International publication number:
WO 2008/011426 (24.01.2008 Gazette 2008/04)

(54)

METHODS AND MEDICAMENTS FOR ADMINISTRATION OF IBUPROFEN

VERFAHREN UND MEDIKAMENTE ZUR VERABREICHUNG VON IBUPROFEN

PROCÉDÉS ET MÉDICAMENTS DESTINÉS À L'ADMINISTRATION D'IBUPROFÈNE


(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

(30) Priority: 18.07.2006 US 489272
18.07.2006 US 489269
24.01.2007 US 897371 P

(43) Date of publication of application:
08.04.2009 Bulletin 2009/15

(60) Divisional application:
12150096.1

(73) Proprietor: Horizon Pharma USA, Inc.
Palo Alto, CA 94031 (US)

(72) Inventors:
  • TIDMARSH, George
    Portola Valley, California 94028 (US)
  • GOLOMBIK, Barry L.
    Incline Village, Nevada 89451 (US)
  • SHARMA, Puneet
    Gaithersburg, Maryland 20882 (US)

(74) Representative: Weiss, Wolfgang et al
Weickmann & Weickmann Patentanwälte Postfach 86 08 20
81635 München
81635 München (DE)


(56) References cited: : 
WO-A-94/07541
WO-A-2007/012022
US-A1- 2006 127 478
WO-A-2007/012019
US-A- 5 976 578
US-B2- 6 926 907
   
  • TAHA ALI S ET AL: "Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs" NEW ENGLAND JOURNAL OF MEDICINE, vol. 334, no. 22, 1996, pages 1435-1439, XP002550689 ISSN: 0028-4793
  • DATABASE EMBASE [Online] ALY ET AL.: 'Formulation and evaluation of famotidine and ibuprofen chewable tablets', XP008102292 Retrieved from STN Database accession no. (2005001773) & JORDAN JOURNAL OF APPLIED SCIENCES-NATURAL SCIENCES vol. 6, no. 2, 2004, pages 1 - 7
  • ROSTOM A ET AL: "Prevention of NSAID-induced gastroduodenal ulcers.", COCHRANE DATABASE OF SYSTEMATIC REVIEWS (ONLINE) 2002 LNKD- PUBMED:12519573, no. 4, 2002, page CD002296, ISSN: 1469-493X
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).